BPC-157 is injected subcutaneously near the injury site or the area you are targeting. The approved injection sites are:
Injecting close to the target area concentrates BPC-157's local angiogenic and repair effects at the site of injury or inflammation, which is why site selection matters more with BPC-157 than with most other peptides.
Musculoskeletal conditions (tendon, ligament, joint, muscle) Inject subcutaneously proximal to (near, but not directly into) the affected area. Your care team will recommend the specific site based on your injury location.
Gastrointestinal conditions (gut health, IBD, leaky gut) The abdomen or thigh are appropriate. Systemic delivery is effective for gut mucosal healing — local proximity to the GI tract is not required.
Your care team can walk you through site selection based on your specific indication. Contact us through the patient portal or call 888-696-7176.